General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(MODEST) RESEARCH/RESEARCH GRANTS: Select Research(NONE), Anumana(NONE) OTHER FINANCIAL BENEFIT: Anumana(NONE), Eko(NONE), Colibri Heart Valves(NONE)

View Full Disclosure